Clinical Trials Sponsored by NeilMed Pharmaceuticals
Total 19768 results
-
University of British ColumbiaThe Craig H. Neilsen FoundationNot yet recruitingCaregiver Burden | Spinal Cord Injuries
-
Brigham and Women's HospitalThe Craig H. Neilsen FoundationRecruitingSpinal Cord InjuriesUnited States
-
ISA PharmaceuticalsRegeneron PharmaceuticalsActive, not recruitingSquamous Cell Carcinoma of the Oropharynx | HPV16 PositiveNetherlands, United States, United Kingdom, France, Belgium, Czechia, Spain, Italy, Germany, Brazil, Hungary, Mexico, Poland
-
Portola PharmaceuticalsCompleted
-
Portola PharmaceuticalsCompleted
-
Portola PharmaceuticalsCompletedHepatic ImpairmentUnited States
-
Portola PharmaceuticalsWithdrawn
-
Jazz PharmaceuticalsGW PharmaceuticalsCompletedSeizures | Tuberous Sclerosis ComplexUnited States
-
Solvay PharmaceuticalsUnimed PharmaceuticalsCompletedPrimary or Secondary Hypogonadism | Constitutional Delay in Growth and Puberty (CDGP)United States
-
Solvay PharmaceuticalsUnimed PharmaceuticalsCompletedPrimary or Secondary Hypogonadism | Constitutional Delay in Growth and Puberty (CDGP)United States
-
Shanghai NewMed Medical Co., Ltd.Shanghai Zhongshan HospitalRecruitingFailing Bioprosthetic ValveChina
-
Portola PharmaceuticalsCompleted
-
Portola PharmaceuticalsWithdrawnAITL | Peripheral T-Cell Lymphoma (PTCL NOS) | Nodal Lymphomas of T Follicular Helper (TFH) | Follicular T-cell Lymphoma (FTCL) | ALCL | HSTCL | EATL I,II | MEITL, EATL Type II | Nasal Lymphoma
-
Portola PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsAlnylam PharmaceuticalsCompleted
-
Ferring PharmaceuticalsXanodyne PharmaceuticalsCompleted
-
ISA PharmaceuticalsRegeneron PharmaceuticalsActive, not recruitingSquamous Cell Carcinoma of the OropharynxUnited States, Israel, Belgium, Germany, Spain, United Kingdom, Italy, France, Czechia
-
Portola PharmaceuticalsCompleted
-
Jazz PharmaceuticalsGW PharmaceuticalsTerminatedRett Syndrome | RTTUnited States, Canada, Italy, Spain, United Kingdom, Australia
-
Alexion PharmaceuticalsPortola PharmaceuticalsCompletedFollicular Lymphoma (FL/Indolent NHL) | Aggressive NHL (a NHL) | Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) | T-cell Lymphoma (PTCL and CTCL) | B-cell Non Hodgkin Lymphoma (NHL)United States
-
University Health Network, TorontoThe Craig H. Neilsen FoundationRecruitingSleep Apnea | Spinal Cord InjuriesCanada
-
Shepherd Center, Atlanta GAThe Craig H. Neilsen FoundationCompletedSpinal Cord Injuries | Cervical Spinal Cord Injury | TetraplegiaUnited States
-
Shepherd Center, Atlanta GAThe Craig H. Neilsen FoundationCompletedSpinal Cord Injuries | TetraplegiaUnited States
-
Boston UniversityThe Craig H. Neilsen Foundation; Northeastern UniversityCompleted
-
University of British ColumbiaThe Craig H. Neilsen FoundationActive, not recruitingSpinal Cord Injuries | Self-Management | Mobile ApplicationCanada
-
NovaBay Pharmaceuticals, Inc.Novum Pharmaceutical Research Services; International Dermatology Research,...Completed
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; Johnson & Johnson Pharmaceutical Research...Completed
-
Shanghai NewMed Medical Co., Ltd.Shanghai Zhongshan HospitalRecruitingAtrioventricular Annular Calcification | Failed Prosthetic Atrioventricular Valve/ Annulus RepairChina
-
NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences...UnknownSexual Dysfunction | Erectile Dysfunction | Secondary HypogonadismUnited States
-
Douglas Pharmaceuticals America LtdNovum Pharmaceutical Research Services; ACM Global LaboratoriesCompleted
-
NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences...CompletedRaynaud's Phenomenon Secondary to Systemic SclerosisUnited States
-
NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences...CompletedOnychomycosis/Onycholysis and Tinea PedisUnited States
-
University of FloridaThe Craig H. Neilsen Foundation; Brooks RehabilitationRecruitingSpinal Cord InjuriesUnited States
-
Regeneron PharmaceuticalsISA Pharmaceuticals B.V.Active, not recruitingCervical CancerSpain, Korea, Republic of, Netherlands, Brazil, Belgium, United States, Italy, Russian Federation
-
Ligand PharmaceuticalsCyDex Pharmaceuticals, Inc.Withdrawn
-
Paratek Pharmaceuticals IncNovartis PharmaceuticalsTerminatedSkin Diseases, InfectiousUnited States
-
Vertex Pharmaceuticals IncorporatedJanssen PharmaceuticalsTerminatedHepatitis CUnited States, United Kingdom, Spain, Belgium, Italy, Germany
-
Eleison Pharmaceuticals LLC.Threshold PharmaceuticalsCompletedSoft Tissue SarcomaUnited States
-
Novartis PharmaceuticalsVanda PharmaceuticalsCompletedSchizophreniaUnited States
-
Endo PharmaceuticalsTeva Pharmaceuticals USACompletedStutteringUnited States
-
Nucorion Pharmaceuticals, Inc.Ligand PharmaceuticalsCompletedChronic Hepatitis BUnited States
-
Semafore PharmaceuticalsSignalRX Pharmaceuticals, Inc.CompletedCancer | Advanced or Metastatic Solid Tumors | Solid CancersUnited States
-
Conatus Pharmaceuticals Inc.Idun PharmaceuticalsCompleted
-
Conatus Pharmaceuticals Inc.Idun PharmaceuticalsCompletedLiver Transplantation | Hepatitis | Carcinoma, Hepatocellular | CholestasisUnited States, Germany
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., BelgiumCompletedNeoplasms | LymphomaUnited Kingdom
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., BelgiumCompletedPharmacokinetics | Advanced Malignancies | Solid Malignancies | Protein Kinase Inhibitors | Maximum Tolerated Dose | Antineoplastic Protocols | Clinical Trial, Phase 1
-
Washington University School of MedicineThe Craig H. Neilsen FoundationCompleted
-
University of FloridaThe Craig H. Neilsen Foundation; Brooks RehabilitationCompleted
-
Washington University School of MedicineThe Craig H. Neilsen FoundationCompleted
-
Institut BergoniéBristol-Myers Squibb; Amgen; Aventis Pharmaceuticals; Sanofi-Synthelabo; Chugai PharmaceuticalCompletedDigestive System Diseases | Lymphoma | Ovarian Diseases | Pulmonary Disease | Bladder Disease | Prostatic DiseaseFrance